42 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded, additional performance … targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt reviews
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
units will vest and, if performance targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms … (i.e. regulatory requirements and the commercial success of the product), the timing of when such revenue targets may occur may change. Such changes
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … to zero if before July 1, 2022
Revenue targets
US$35,000,000 upon Oleogel-S10 revenues exceeding US$75,000,000 in any 12-month period prior to June 30
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
7:45am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … of the product), the timing of when such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected
6-K
EX-99.1
AMYT
Amryt Pharma Plc
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
period to March 31, 2022. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded … such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt
424B3
beigj3u
9 Mar 22
Prospectus supplement
9:26am
424B3
pj4ayew447
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
xnpow01bkyz6jl
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
0idukqtwizvh43
22 Nov 21
Prospectus supplement
7:39am
424B3
k948okxw
22 Nov 21
Prospectus supplement
7:38am
6-K
EX-99.3
kmyiuaj 7l
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
ve6nzypr
3 Nov 21
Prospectus supplement
7:33am
424B3
y6kbwf0dw246m
3 Nov 21
Prospectus supplement
7:32am
6-K
EX-99.1
ylwqlegmajr
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
EX-99.2
qneogd
13 Sep 21
Current report (foreign)
8:48am
424B3
8tmjntfkf1 hch0
6 Aug 21
Prospectus supplement
8:18am
6-K
EX-99.1
x4ozldujw1yod681
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
8s0frfcgozr2z8izm
6 Aug 21
Prospectus supplement
8:17am
424B3
5u2a zdotzwn0z158l
1 Jul 21
Prospectus supplement
5:20pm